LENZ Therapeutics (LENZ) Common Equity (2020 - 2026)
LENZ Therapeutics (LENZ) reported Common Equity of $192 million for Q3 2026, down 1.0% from $193.93 million a year earlier and down 12.4% from the prior quarter.
Powered by 
Analysis
LENZ Therapeutics (LENZ) Common Equity (2020 - 2026) Analysis & Trends
At the end of FY2025, LENZ Therapeutics posted Common Equity of $284.34 million, up 39.3% from FY2024.
- By year, Common Equity came in at $204.08 million in FY2024, -$92.71 million in FY2023, -$24.17 million in FY2022 and $384.05 million in FY2021.
- The Q3 2026 figure ranks as the lowest quarterly Common Equity since Q4 2023.
- Year over year, Common Equity gained in four of the last seven quarters, with growth averaging 9.6%.
- The high point for year-over-year Common Equity in five years was Q4 2025 (growth of 39.3%); the low point was Q3 2022 (a decline of 20.9%).
- Per Business Quant data, the three quarters before Q3 2026 came in at $219.26 million (Q2 2026), $246.49 million (Q1 2026) and $284.34 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 40.27 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 81.53 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | -4.58 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 44.95 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 51.81 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 14.35 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 13.04 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 89.30 Bn |
| 10 | LENZ Therapeutics | 128.82 Mn | -839.21 Mn | 2.93 Mn | 192.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 192.00 Mn |
| Jun 30, 2026 | 219.26 Mn |
| Mar 31, 2026 | 246.49 Mn |
| Dec 31, 2025 | 284.34 Mn |
| Sep 30, 2025 | 193.93 Mn |
| Jun 30, 2025 | 206.37 Mn |
| Mar 31, 2025 | 192.01 Mn |
| Dec 31, 2024 | 204.08 Mn |
| Sep 30, 2024 | 215.28 Mn |
| Jun 30, 2024 | 192.92 Mn |
| Mar 31, 2024 | 198.17 Mn |
| Dec 31, 2023 | -92.71 Mn |
| Sep 30, 2023 | -69.57 Mn |
| Jun 30, 2023 | -51.21 Mn |
| Mar 31, 2023 | -36.68 Mn |
| Dec 31, 2022 | -24.17 Mn |
| Sep 30, 2022 | 316.45 Mn |
| Jun 30, 2022 | 338.46 Mn |
| Mar 31, 2022 | 361.30 Mn |
| Dec 31, 2021 | 384.05 Mn |
API Access
LENZ Therapeutics Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=LENZ&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "LENZ", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=LENZ&period=max&api_key=YOUR_API_KEY");
const data = await res.json();